List of works - Mary-Anne Trabaud

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure

article

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

scientific article published on 25 October 2014

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

scientific article published on 2 May 2017

Antitetanus vaccination by Polan T in the elderly: followed of the immune response by Vaccitest T after vaccination and booster

scientific article published on 01 January 1991

Can virostatic chemotherapy and/or adoptive allogeneic immunotherapy eradicate in vivo Friend's virus infection?

scientific article published on January 1, 1990

Comparison between direct binding, competition and agglutination assays in the characterization of polyclonal anti-idiotypes against anti-HBs human monoclonal antibodies ⬇️

scientific article published on March 15, 1993

Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.

scientific article published on 07 June 2017

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion ⬇️

scientific article published on May 1, 1991

Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1 ⬇️

scientific article published on September 1, 1997

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

scientific article published on 3 January 2015

Discordance in HIV‐1 Co‐receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions ⬇️

scientific article published on March 1, 2012

Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen

scientific article

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

scientific article

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

scientific article

HIV-1 Load Comparison Using Four Commercial Real-Time Assays ⬇️

scientific article published on November 10, 2010

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

scientific article published on 13 December 2017

In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype ⬇️

scientific article published on May 15, 1998

Virological failure of patients on maraviroc-based antiretroviral therapy

scientific article published on 19 February 2015

List of works by Mary-Anne Trabaud

A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

Antitetanus vaccination by Polan T in the elderly: followed of the immune response by Vaccitest T after vaccination and booster

Can virostatic chemotherapy and/or adoptive allogeneic immunotherapy eradicate in vivo Friend's virus infection?

Comparison between direct binding, competition and agglutination assays in the characterization of polyclonal anti-idiotypes against anti-HBs human monoclonal antibodies ⬇️

Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion ⬇️

Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1 ⬇️

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

Discordance in HIV‐1 Co‐receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions ⬇️

Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

HIV-1 Load Comparison Using Four Commercial Real-Time Assays ⬇️

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype ⬇️

Virological failure of patients on maraviroc-based antiretroviral therapy